A new study funded by the National Institutes of Health will be evaluating treatment options for newborns experiencing opioid withdrawal syndrome.
This syndrome is caused by exposure to opioids during pregnancy. Apart from the possibility of affecting the health and well-being of pregnant women, drug-use during pregnancy can also lead to withdrawal symptoms in the newborn characterized by tremors, and excessive crying amongst others.
Matthew W. Gillman, M.D., ECHO Director, says, ‘This project will allow researchers to evaluate the impact of neonatal opioid withdrawal syndrome across the country and to develop a multi-site clinical trial in areas hit hard by the opioid crisis”.
Read more about this upcoming study in this Eunice Kennedy Shriver National Institute of Child Health and Human Development news article: